30 Oct 2024 R&D Spotlight focusing on pre|CISION® technology and pipeline advances Investors | Podcasts and Videos
24 Oct 2024 Avacta Reports Pipeline Advances with Two Novel Programs at the EORTC-NCI-AACR Molecular Targets Symposium in Barcelona Investors | Therapeutics
21 Oct 2024 Avacta and Tempus Enter Strategic Collaboration to Advance AI-Driven Drug Development in Oncology Investors | Therapeutics
17 Oct 2024 Avacta Expands its Pipeline with Two Novel Assets Developed Using its pre|CISION® Platform Investors | Therapeutics
15 Oct 2024 Avacta Group strengthens executive team with appointment of Michelle Morrow, PhD as Chief Scientific Officer Investors | Therapeutics
10 Oct 2024 Avacta to Unveil Pipeline Expansion and Novel, Next-Generational Targeted Cancer Therapy Programs at 2024 EORTC-NCI-AACR Symposium Investors | Therapeutics